// August 29, 2023
Part two: Industry examining FDA guidance on nitrosamines
This summer, a wave of regulatory activity on nitrosamines has taken place, with agencies fro
This summer, a wave of regulatory activity on nitrosamines has taken place, with agencies fro
Nitrosamine impurities in pharmaceutical products have been making major headlines recently, as t
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Revised on: January 17, 2023